A major step forward, with important implications for understanding how to reduce the severity of multiple sclerosis
, has been made by scientists at the University
of Bristol. The results are published online today in PNAS.
The team found that mice designed to express a large amount of the neuropeptide ‘galanin’ were completely resistant to the MS-like disease, experimental autoimmune encephalomyelitis (EAE).